Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094159 · ClinicalTrials.gov registry record · Phase 1
Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
A Phase 1 study, sponsored by Sunesis Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00094159: Completed Phase 1 study, sponsored by Sunesis Pharmaceuticals.
NCT00094159 is a Phase 1 study that has completed, run by Sunesis Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094159, a Phase 1 study, has completed, sponsored by Sunesis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to determine whether SNS-595 given intravenously weekly for 3 weeks is safe.
Interventions
- DRUG SNS-595
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-10 |
| Phase | Phase 1 |
What the finished NCT00094159 record still lists
NCT00094159 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which SNS-595 is the first listed.
NCT00094159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00094159 about?
NCT00094159 is a clinical study titled "Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors". The purpose of this study is to determine whether SNS-595 given intravenously weekly for 3 weeks is safe.
What is the current status of trial NCT00094159?
This trial is currently completed. It is a Phase 1 study. The study started on 2004-10.
What interventions are being tested in trial NCT00094159?
The interventions under investigation include: SNS-595 (DRUG).
Who is sponsoring clinical trial NCT00094159?
This trial is sponsored by Sunesis Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia